secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2026-06-11T20:32:54+00:00
Accession:  0001628280-26-042525
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira stockholders elect all three company director nominees; 2011 stock incentive plan fails
--------------------------------------------------------------------------------

- All three company nominees (Christie, Hirawat, Wiggans) elected with ~25-28M votes; dissident slate from DOMA defeated with ~4.6M votes.
- 2011 Stock Incentive Plan failed: 14.2M for, 18.4M against; requires >50% approval.
- ESPP approved: 29.1M for, 3.5M against; share reserve increased by 800,000 shares.
- Say-on-pay passed 19.5M for vs 13.1M against; 452K broker non-votes.
- Board committee assignments updated; new chairs: Young (Audit), Yang (People/Comp), Christie (Nominating).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/0001628280-26-042525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/pcrx-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-042525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer